I agree that this site is using cookies. You can find further informations here.
X
Shore, Neal D.
519  results:
Online X
Search for persons X
?
1

TREATMENT OF LOW-GRADE INTERMEDIATE-RISK NONMUSCLE-INVASIVE..:

Prasad, Sandip M. ; Huang, William C. ; Shore, Neal D....
Urologic Oncology: Seminars and Original Investigations.  42 (2024)  - p. S57 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Complications of immuno‐oncology care: what urologist shoul..:

Grajales, Valentina ; Martini, Alberto ; Shore, Neal D.
BJU International.  133 (2024)  5 - p. 524-531 , 2024
Link: https://doi.org/10.1111/..
 
?
3

Interruptions in bladder cancer care during the COVID-19 pu..:

Gore, John L. ; Follmer, Kristin ; Reynolds, Jason...
Urologic Oncology: Seminars and Original Investigations.  42 (2024)  4 - p. 116.e17-116.e21 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Pembrolizumab and Enzalutamide in Patients with Abiraterone..:

Yu, Evan Y. ; Berry, William R. ; Gurney, Howard...
European Urology Oncology.  7 (2024)  3 - p. 509-518 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Correction: A multidisciplinary approach to address unmet n..:

Shore, Neal D. ; Antonarakis, Emmanuel S. ; Ross, Ashley E....
Prostate Cancer and Prostatic Diseases.  , 2024
Link: https://doi.org/10.1038/..
 
?
6

Mechanism of action of nadofaragene firadenovec-vncg:

Narayan, Vikram M. ; Meeks, Joshua J. ; Jakobsen, Jørn S....
Frontiers in Oncology.  14 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
7

CHARACTERISTICS, TREATMENTS, AND OUTCOMES OF PATIENTS WITH ..:

Karsh, Lawrence ; Symanowski, James ; Shore, Neal...
Urologic Oncology: Seminars and Original Investigations.  42 (2024)  - p. S16-S17 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Novel hormone therapy and coordination of care in high-risk..:

Efstathiou, Jason A. ; Morgans, Alicia K. ; Bland, Christopher S..
Cancer Treatment Reviews.  122 (2024)  - p. 102630 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Patterns of treatment of high-risk BCG-unresponsive non-mus..:

Moussa, Mohamad ; Abou Chakra, Mohamad ; Shore, Neal D....
Archivio Italiano di Urologia e Andrologia.  96 (2024)  1 - p. , 2024
Link: https://doi.org/10.4081/..
 
?
10

Publisher Correction: First-line talazoparib with enzalutam..:

Fizazi, Karim ; Azad, Arun A. ; Matsubara, Nobuaki...
Nature Medicine.  30 (2024)  5 - p. 1505-1505 , 2024
Link: https://doi.org/10.1038/..
 
?
11

A multidisciplinary approach to address unmet needs in the ..:

Shore, Neal D. ; Antonarakis, Emmanuel S. ; Ross, Ashley E....
Prostate Cancer and Prostatic Diseases.  , 2024
Link: https://doi.org/10.1038/..
 
?
12

Differences in real‐world outcomes by risk classification f..:

Karsh, Lawrence ; Du, Shawn ; He, Jinghua...
The Prostate.  84 (2024)  11 - p. 1047-1055 , 2024
Link: https://doi.org/10.1002/..
 
?
13

ADVANCED-1: PHASE 1A DOSE-FINDING, OPEN-LABEL STUDY TO EVAL..:

Bandari, Jathin ; Jayram, Gautam ; Tabayoyong, William...
Urologic Oncology: Seminars and Original Investigations.  42 (2024)  - p. S61 , 2024
Link: https://doi.org/10.1016/..
 
?
14

Expert Perspectives on Controversies in Metastatic Castrati..:

Bryce, Alan H. ; Crawford, E. David ; Agarwal, Neeraj...
JU Open Plus.  2 (2024)  4 - p. , 2024
Link: https://doi.org/10.1097/..
 
?
15

REAL-WORLD CLINICAL OUTCOMES OF MEDICARE PATIENTS WITH HIGH..:

Karsh, Lawrence ; Du, Shawn ; He, Jinghua..
Urologic Oncology: Seminars and Original Investigations.  42 (2024)  - p. S16 , 2024
Link: https://doi.org/10.1016/..
 
1-15